Product Information
VEOZAH 45 MG TABLET is a brand product labeled by Astellas Pharma US, Inc., priced at $18.5822 per EA under NDC 00469266030. Its NADAC has been published 159 times since Sep 20, 2023.
FDA first approved this application on May 12, 2023.
Strength
45 mg/1
Manufacturer
Astellas Pharma US, Inc.NDC
00469266030
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FEZOLINETANTApproval Type
New Drug (NDA)
FDA Application
NDA216578FDA Approved
5/12/2023
On Market Since
5/12/2023
Pharmacological Classes
Price Statistics
The NADAC for VEOZAH 45 MG TABLET has been published 159 times since Sep 20, 2023, and over the history we have for it it has risen 6.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.5822 per EA |
|---|---|
| All-time high | $18.6256 (May 13, 2026) |
| All-time low | $17.5288 (Sep 20, 2023) |
| 52-week high | $18.6256 |
| 52-week low | $18.0586 |
| Median price | $18.0681 |
| Average price | $17.9775 |
| Largest weekly change | +3.0% (Jan 21, 2026) |
| Weeks tracked | 159 |
| Tracking since | Sep 20, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fezolinetant market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Astellas Pharma US, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fezolinetant market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VEOZAH 45 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VEOZAH 45 MG TABLET, manufactured by Astellas Pharma US, Inc., is $18.5822 per EA (NDC 00469266030), effective Sep 30, 2026.
How has the price of VEOZAH 45 MG TABLET changed over time?
Over the history we have for it, the NADAC for VEOZAH 45 MG TABLET has risen 6.0%. It has been tracked across 159 weekly CMS publications since Sep 20, 2023.
What are the highest and lowest recorded NADAC prices for VEOZAH 45 MG TABLET?
Since Sep 20, 2023, the NADAC for VEOZAH 45 MG TABLET has ranged from a low of $17.5288 (Sep 20, 2023) to a high of $18.6256 (May 13, 2026), with a median of $18.0681 per EA.
Are there cheaper alternatives to VEOZAH 45 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of VEOZAH 45 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VEOZAH 45 MG TABLET?
VEOZAH 45 MG TABLET (NDC 00469266030) is labeled by Astellas Pharma US, Inc., and CMS classifies it as a brand product.